{"entity":{"id":"dachverband-sozialversicherung","kind":"institution","name":"Federation of Austrian Social Insurance Institutions (Dachverband der Sozialversicherungsträger)","aka":["Dachverband der Sozialversicherungsträger","Dachverband","Hauptverband der österreichischen Sozialversicherungsträger"],"tldr":"The umbrella body of Austria's social insurance funds. It runs the Erstattungskodex, the list of medicines that social insurance pays for outside hospital, and agrees with MedAustron the indications for which ion therapy is covered.","summary":"Under section 351c of the General Social Insurance Act, a marketing authorisation holder applies to the Dachverband for a medicine to be listed in the yellow or green area of the Erstattungskodex. A complete application, with the authorisation number, a price, confirmation of supply and the patent expiry date, places the medicine temporarily in the red area; if the Dachverband decides within 90 days, or 180 days where a price is also decided, that it should not be listed, it is removed. Applicants must submit pharmacological, medical-therapeutic and health-economic evidence on the medicine's therapeutic benefit, and for the red and yellow areas a pricing commission sets an EU average price from member states' prices. The Dachverband may also start a listing procedure itself.\n\nThe OECD and European Commission's 2025 profile records that the 2020 reform merged 21 social health insurance funds into five. MedAustron states that patients insured in Austria are generally covered for ion therapy when the indication is on the list agreed with the Federation of Austrian Social Insurance Institutions.","asOf":"2026-11-11","links":[{"label":"§ 351c ASVG, Erstattungskodex (JUSLINE consolidated text)","url":"https://www.jusline.at/gesetz/asvg/paragraf/351c"},{"label":"MedAustron: insurance","url":"https://www.medaustron.at/en/insurance/"},{"label":"OECD/EC, Country Cancer Profile Austria 2025, section 5.1 (PDF)","url":"https://cancer-inequalities.jrc.ec.europa.eu/sites/default/files/docs/ccp2025/ec-oecd-at-2024-1658-en.pdf"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["oegk-austria","medaustron","bmasgpk-austria"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Vienna","country":"AT","lat":48.208,"lng":16.373,"institutionType":"government","website":"https://www.sozialversicherung.at","programs":["Erstattungskodex (outpatient reimbursement list: red, yellow and green areas)","Coordination of the five social insurance funds"]},"route":"/institutions/dachverband-sozialversicherung/","neighbours":{"institution":[{"id":"oegk-austria","kind":"institution","name":"Austrian Health Insurance Fund (Österreichische Gesundheitskasse)","route":"/institutions/oegk-austria/"},{"id":"bmasgpk-austria","kind":"institution","name":"Federal Ministry of Labour, Social Affairs, Health, Care and Consumer Protection, Austria","route":"/institutions/bmasgpk-austria/"},{"id":"medaustron","kind":"institution","name":"MedAustron","route":"/institutions/medaustron/"}]}}